)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Elicio Therapeutics
Elicio Therapeutics (ELTX) investor relations material
Elicio Therapeutics Registration Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration Filing summary12 Mar, 2026
Company overview and business model
Clinical-stage biotechnology company developing novel immunotherapies for cancer, focusing on mKRAS-positive pancreatic, colorectal, lung, and other cancers.
Proprietary AMP technology enhances T cell responses by targeting lymph nodes, aiming for durable cancer immunosurveillance.
Lead candidate ELI-002 7P is in Phase 2 for mKRAS-driven pancreatic cancer, with plans to expand to other indications.
Pipeline includes preclinical candidates for b-raf and p53-mutated cancers.
Completed a reverse merger in 2023, now headquartered in Boston, MA.
Financial performance and metrics
Audited financial statements for the year ended December 31, 2025, are incorporated by reference.
Auditor's report includes a going concern explanatory paragraph.
Use of proceeds and capital allocation
Net proceeds intended for working capital, R&D, business expansion, strategic transactions, and general corporate purposes.
Pending use, proceeds may be invested in investment-grade, interest-bearing securities.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Elicio Therapeutics
- Reduced net loss, strong cash position, and key clinical milestones expected in 2026.ELTX
Q4 202513 Mar 2026 - Phase II data for a lymph node-targeted KRAS immunotherapy show robust T cell responses and safety.ELTXTD Cowen 46th Annual Health Care Conference4 Mar 2026
- Shelf registration allows ongoing securities offerings with robust governance protections.ELTXRegistration Filing2 Mar 2026
- Biotech seeks up to $400M via flexible securities shelf to advance immunotherapy pipeline.ELTXRegistration Filing27 Feb 2026
- 2.25 million shares registered for resale by a board-controlled entity after recent private placements.ELTXRegistration Filing16 Dec 2025
- Biotech seeks up to $200M, including $40M at-the-market, to fund immunotherapy pipeline.ELTXRegistration Filing16 Dec 2025
- Registration enables resale of shares from a $20M convertible note, with no proceeds to the company.ELTXRegistration Filing16 Dec 2025
- Registering 103,225 shares for resale from a warrant linked to a $10M note, with Phase 2 cancer immunotherapy in focus.ELTXRegistration Filing16 Dec 2025
- Shareholder approval sought for major share issuances that may trigger a change of control.ELTXProxy Filing2 Dec 2025
Elicio Therapeutics
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Elicio Therapeutics Inc. is a biotechnology company focused on developing immunotherapies for the treatment of cancer and infectious diseases. The company specializes in AMP (Amphiphile) platform technology, designed to enhance the delivery of cancer vaccines and immunomodulators to the lymphatic system, improving immune response. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage